logo

For the Inventor, By the Inventor

Tokyo, Japan

Koichi Shudo

This inventor holds 55 USPTO granted patents and 1 published patent application and 4 EPO patents, primarily in Pharmaceutical Compounds (CPC class A61K). Top assignees: Kemphys Ltd., Research Foundation Itsuu Laboratory, Shionogi Company Limited. Active years: 1980-2019.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Koichi Shudo. Retrieved from https://idiyas.com/inventor/koichi-shudo

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 55 

% Patents Active = 60.0

 

Average Co-Inventor Count = 2.3

ph-index = 10

Forward Citations = 358(Granted Patents)

Forward Citations (Not Self Cited) = 325(Dec 10, 2025)


Inventors with similar research interests:


Location History:

  • Totsukaku, Yokohama, JP (1980)
  • Yokohamashi, Kanagawa, JP (1981)
  • Kosugayacho, Totsukaku, Yokohamashi, Kanagawa, JP (1982)
  • Totsukaku, Yokohamashi, Kanagawa, JP (1981 - 1983)
  • Higashiyama, Meguroku Tokyo, JP (1987)
  • Mishuku-jutaku Higashiyama, Meguro-ku, Tokyo, JP (1987)
  • Higashiyama, Meguroku, Tokyo, JP (1988)
  • Higashiyama, Megura-ku, Tokyo, JP (1995)
  • Suginami-ku, Tokyo, JP (1997)
  • Suginami-ku, Tokyo JP (1998)
  • Tokyo-to, JP (2013)
  • Tokyo, JP (1989 - 2019)

Company Filing History:

goldMedal12 out of 12 
 
Kemphys Ltd.
 patents
silverMedal11 out of 14 
 
Research Foundation Itsuu Laboratory
 patents
bronzeMedal6 out of 1,001 
 
Shionogi Company Limited
 patents
4. 5 out of 6 
 
Koichi Shudo
 patents
5. 4 out of 66 
 
Hoechst Japan Limited
 patents
6. 4 out of 382 
 
Meiji Seika Kaisha, Ltd.
 patents
7. 3 out of 21 
 
Institute of Medicinal Molecular Design, Inc.
 patents
8. 3 out of 1,858 
 
Takeda Chemical Industries, Inc.
 patents
9. 1 out of 4 
 
Nanoegg Research Laboratories, Inc.
 patents
10. 1 out of 1 
 
Research Founation Itsuu Laboratory
 patent
11. 1 out of 1 
 
Shionogi Pharmaceutical Co., Ltd.
 patent
12. 1 out of 320 
 
Taiho Pharmaceutical Company Limited
 patents
13. 1 out of 4 
 
Tokyo Metropolitan Institute for Neurosciences
 patents
14. 1 out of 60 
 
Tsumura Co., Ltd.
 patents
15. 16 out of 834,513 
Other
 patents
where one patent can have more than one assignee

Years Active: 1980-2019

Loading Chart...
Loading Chart...
Areas of Expertise:
Neuropathic Disease
Alzheimer's Treatment
Heterocyclic Compound
Serotonin Receptor Agonist
Pharmacological Effects
Anti-Wrinkle Agent
Memory Consolidation
Cancer Metastasis Inhibitor
Carboxylic Acid Derivative
Tricyclic Amide
Vitamin E-Like Activities
Organ Formation
55 patents (USPTO):Explore Patents
1. 10485776 - Medicament for therapeutic treatment of neuropathic disease (2019-11-26),
2. 10004710 - Medicament for therapeutic treatment of neuropathic disease (2018-06-26),
3. 9861640 - Medicament for treatment of Alzheimer's disease (2018-01-09),
4. 9353134 - Silicon-containing carboxylic acid derivative (2016-05-31),
5. 8895769 - Silicon-containing carboxylic acid derivative (2014-11-25),
6. 8785625 - Compound having heterocyclic ring (2014-07-22),
7. 8722730 - 5-membered heterocyclic compound (2014-05-13),
8. 8722723 - Aromatic amide derivative (2014-05-13),
9. 8633335 - Retinoid prodrug compound (2014-01-21),
10. 8530646 - Oxazolidinone derivative having 7-membered hetero ring (2013-09-10),
11. 8431613 - Memory fixation accelerator (2013-04-30),
12. 8232300 - Tricyclic amide compound (2012-07-31),
13. 8198329 - Memory consolidation promoting agent and method of use (2012-06-12),
14. 8168677 - Method for treatment of inflammatory bowel disease (2012-05-01),
15. 8148362 - Compound having heterocyclic ring (2012-04-03),

Title: **Koichi Shudo: Innovator in Neuropathic Disease Treatment**

Introduction

Koichi Shudo, based in Tokyo, Japan, is a prominent inventor known for his significant contributions to the field of medicinal treatments. With an impressive portfolio of 55 patents, Shudo has dedicated his career to developing innovative solutions for healthcare challenges, particularly in neuropathic diseases.

Latest Patents

Among his latest innovations is a medicament designed for the therapeutic treatment of neuropathic diseases. This medicament is formulated as an external preparation aimed at alleviating local symptoms associated with neuropathic conditions, utilizing either gabapentin or pregabalin in the form of an aqueous solution. His dual patent on this treatment highlights the effectiveness and importance of his work in addressing complex health conditions.

Career Highlights

Throughout his career, Shudo has worked at various reputable companies, including Kemphys Ltd. His extensive experience in the pharmaceutical industry has enabled him to refine his research and development skills, leading to groundbreaking inventions in the field of medicine.

Collaborations

Collaboration has been a key aspect of Shudo's career, working alongside talented professionals such as Katsuyoshi Iwamatsu and Yasuo Sato. These partnerships have fostered an environment of creativity and innovation, allowing for the development of effective treatments that benefit many patients.

Conclusion

Koichi Shudo continues to be a driving force in the development of therapeutic treatments for neuropathic diseases. His commitment to innovation is evident in his extensive patent portfolio and collaborative efforts with other skilled professionals. As the landscape of medical treatment evolves, Shudo's contributions remain vital to the advancement of healthcare.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…